OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Klein on Challenges With Active Surveillance in Prostate Cancer

June 19th 2020

Eric A. Klein, MD, discusses challenges with active surveillance in prostate cancer.

Dr. Leonard on the FDA Approval of Tazemetostat in Follicular Lymphoma

June 18th 2020

John P. Leonard, MD, discusses the FDA approval of tazemetostat in follicular lymphoma.

Dr. Jacobson on Design of ZUMA-5 Trial in R/R Indolent Non-Hodgkin Lymphoma

June 18th 2020

Caron Jacobson, MD, discusses the design of the phase 2 ZUMA-5 trial in patients with relapsed/refractory indolent non-Hodgkin lymphoma.

Dr. Hoffman on the Mechanism of Action of PTG-300 in Polycythemia Vera

June 18th 2020

Ronald Hoffman, MD, discusses the mechanism of action of the investigational hepcidin mimetic PTG-300 in polycythemia vera.

Dr. Rutherford on the Importance of Including Patients With Double-Hit Lymphoma in Clinical Trials

June 18th 2020

Sarah Rutherford, MD, discusses the importance of including patients with double-hit lymphoma in clinical trials.

Dr. Ghosh on the Need to Develop Novel Therapies in DLBCL

June 18th 2020

Nilanjan Ghosh, MD, PhD, discusses the need to develop novel therapies in diffuse large B-cell lymphoma.

Dr. Katz on the Oncotype DX GPS Assay in Prostate Cancer

June 18th 2020

Aaron E. Katz, MD, FACS, discusses the Oncotype DX Genomic Prostate Score assay in patients with prostate cancer.

Dr. Awad on Objectives of the Phase 2 GEOMETRY Mono-1 Study in NSCLC

June 18th 2020

Mark M. Awad, MD, PhD, discusses the main objectives of the phase 2 GEOMETRY mono-1 study in patients with MET exon 14 skipping (METex14)-mutated non–small cell lung cancer (NSCLC).

Dr. Woyach on the Safety Profiles of BTK Inhibitors in CLL

June 18th 2020

Jennifer Woyach, MD, discusses the safety profiles of BTK inhibitors in patients with chronic lymphocytic leukemia.

Dr. Sartor on Outcomes With 177Lu-PSMA-617 After Radium-223 in mCRPC

June 18th 2020

A. Oliver Sartor, MD, discusses the design of the REASSURE trial (NCT02141438) in patients with metastatic castration-resistant prostate cancer.

Dr. Janjigian on Pembrolizumab Triplet in HER2+ Esophagogastric Cancer

June 17th 2020

Yelena Y. Janjigian, MD, discusses the rationale behind the plasma and tumor-based biomarker analysis of pembrolizumab in combination with trastuzumab and chemotherapy in HER2-positive metastatic esophagogastric cancer.

Dr. Lee on the Combination of Immunotherapy and TKIs in mRCC

June 17th 2020

Chung-Han Lee, MD, PhD, discusses the efficacy of combining immunotherapy with TKIs to treat patients with metastatic renal cell carcinoma.

Dr. Daver on the Mechanism of Action of Magrolimab in AML/MDS

June 17th 2020

Naval G. Daver, MD, discusses the mechanism of action of the investigational CD47-directed antibody magrolimab in acute myeloid leukemia and myelodysplastic syndrome.

Dr. Sartor on Sequential Use of Beta and Alpha Emitters in mCRPC

June 17th 2020

A. Oliver Sartor, MD, discusses the rationale for investigating the sequential use of beta emitters and alpha emitters in metastatic castration-resistant prostate cancer.

Dr. Gafita on Sequencing 177Lu-PSMA-617 in mCRPC

June 17th 2020

Andrei Gafita, MD, discusses sequencing lutetium-177 PSMA-617 in metastatic castration-resistant prostate cancer.

Dr. Cortes on the Benefit of Ruxolitinib in MPNs

June 17th 2020

Jorge E. Cortes, MD, discusses the benefits of ruxolitinib (Jakafi) in patients with myeloproliferative neoplasms.

Dr. Lonial on Emerging Concepts in Multiple Myeloma Treatment

June 17th 2020

Sagar Lonial, MD, FACP, discusses some of the remaining challenges to address in the multiple myeloma space.

Dr. Chi on the Rationale for the PC-BETS Study With ctDNA in Prostate Cancer

June 16th 2020

Kim Chi, MD, senior research scientist, Vancouver Prostate Centre, discusses clinical challenges in prostate cancer.

Dr. Slomovitz on Sequencing Strategies for Endometrial Cancer

June 16th 2020

Brian M. Slomovitz, MD, discusses sequencing strategies for endometrial cancer.

Dr. Gupta on Neoadjuvant Versus Adjuvant Immunotherapy in Urothelial Carcinoma

June 16th 2020

Shilpa Gupta, MD, discusses the potential utility of neoadjuvant versus adjuvant immunotherapy in urothelial carcinoma.